The delayed hypersensitivity reaction in breast cancer

Abstract

Women with breast cancer confined to the breast (stage I) have a reduced dermal delayed hypersensitivity reaction to Varidase; the degree of anergy to this antigen increases as the disease progresses. The in vitro reaction to phytohaemagglutinin, however, remains normal throughout the course of the disease.